| Status | Acronym | ISRCTN | EudraCT | NCT (clinicaltrials.gov) | DRKS |
|---|---|---|---|---|---|
| Active |
Lean European Open Survey on SARS-CoV-2
Purpose / Objectives
Primary Outcome
To identify independent predictors of outcome in patients with diagnosed infection by SARS-CoV-2.
Diagnosis
- COVID-19 infection
infection by SARS-CoV-2.
Target population
Age
18-
Inclusion criteria
Patients with confirmed SARS-CoV-2 infection by PCR diagnosis from nasopharynx, oropharynx, stool, or blood. Rapid tests are an acceptable alternative.
Exclusion criteria
The study will be governed, announced, and disseminated via ESCMID and other channels across Europe. However, treatment in another country is not a formal exclusion criterion.
Study design
- Multicenter
- Prospective
- Retrospective
Intervention
none
Miscellaneous
none
Documents (password protected)
Go to download area (no documents yet)
Networks
Responsibilities in overall study
Sponsor
Universität zu Köln
- Tel. +49 (0)221 478 0
(National) Coordinating Investigator
Univ.-Prof. Dr. med. Jörg Janne Vehreschild